Attend Free Live Webinars on
WHO Group 3 Pulmonary
Hypertension Patients
New Live Webinars
Presented by Expert Faculty
Not available for CME/CE credit
Series Overview
WHO Group 3 pulmonary hypertension is a complex form
of pulmonary hypertension manifested as a varying
combination of hypoxia induced pulmonary
vasoconstriction and interstitial pulmonary fibrosis. These
programs examine the pathophysiology, epidemiology,
and diagnosis of Group 3 pulmonary hypertension. With
no currently approved medical therapies for Group 3 PH,
the data for and against use of Group 1 PAH medications
are considered with examples using patient case data.